These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30796626)

  • 1. Characterization of the binding of tau imaging ligands to melanin-containing cells: putative off-target-binding site.
    Tago T; Toyohara J; Harada R; Furumoto S; Okamura N; Kudo Y; Takahashi-Fujigasaki J; Murayama S; Ishii K
    Ann Nucl Med; 2019 Jun; 33(6):375-382. PubMed ID: 30796626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head to head comparison of [
    Jang YK; Lyoo CH; Park S; Oh SJ; Cho H; Oh M; Ryu YH; Choi JY; Rabinovici GD; Kim HJ; Moon SH; Jang H; Lee JS; Jagust WJ; Na DL; Kim JS; Seo SW
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):432-442. PubMed ID: 29143870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.
    Lemoine L; Gillberg PG; Svedberg M; Stepanov V; Jia Z; Huang J; Nag S; Tian H; Ghetti B; Okamura N; Higuchi M; Halldin C; Nordberg A
    Alzheimers Res Ther; 2017 Dec; 9(1):96. PubMed ID: 29229003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual tracer tau PET imaging reveals different molecular targets for
    Chiotis K; Stenkrona P; Almkvist O; Stepanov V; Ferreira D; Arakawa R; Takano A; Westman E; Varrone A; Okamura N; Shimada H; Higuchi M; Halldin C; Nordberg A
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1605-1617. PubMed ID: 29752516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case.
    Marquié M; Verwer EE; Meltzer AC; Kim SJW; Agüero C; Gonzalez J; Makaretz SJ; Siao Tick Chong M; Ramanan P; Amaral AC; Normandin MD; Vanderburg CR; Gomperts SN; Johnson KA; Frosch MP; Gómez-Isla T
    Acta Neuropathol Commun; 2017 Oct; 5(1):75. PubMed ID: 29047416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.
    Harada R; Okamura N; Furumoto S; Furukawa K; Ishiki A; Tomita N; Tago T; Hiraoka K; Watanuki S; Shidahara M; Miyake M; Ishikawa Y; Matsuda R; Inami A; Yoshikawa T; Funaki Y; Iwata R; Tashiro M; Yanai K; Arai H; Kudo Y
    J Nucl Med; 2016 Feb; 57(2):208-14. PubMed ID: 26541774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [
    Ng KP; Therriault J; Kang MS; Struyfs H; Pascoal TA; Mathotaarachchi S; Shin M; Benedet AL; Massarweh G; Soucy JP; Rosa-Neto P; Gauthier S
    Neuroimage Clin; 2019; 24():102091. PubMed ID: 31795034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies.
    Marquié M; Normandin MD; Meltzer AC; Siao Tick Chong M; Andrea NV; Antón-Fernández A; Klunk WE; Mathis CA; Ikonomovic MD; Debnath M; Bien EA; Vanderburg CR; Costantino I; Makaretz S; DeVos SL; Oakley DH; Gomperts SN; Growdon JH; Domoto-Reilly K; Lucente D; Dickerson BC; Frosch MP; Hyman BT; Johnson KA; Gómez-Isla T
    Ann Neurol; 2017 Jan; 81(1):117-128. PubMed ID: 27997036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging-pathological correlations of [
    Ishiki A; Harada R; Kai H; Sato N; Totsune T; Tomita N; Watanuki S; Hiraoka K; Ishikawa Y; Funaki Y; Iwata R; Furumoto S; Tashiro M; Sasano H; Kitamoto T; Kudo Y; Yanai K; Furukawa K; Okamura N; Arai H
    Acta Neuropathol Commun; 2018 Jun; 6(1):53. PubMed ID: 29958546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase B inhibitor, selegiline, reduces
    Ng KP; Pascoal TA; Mathotaarachchi S; Therriault J; Kang MS; Shin M; Guiot MC; Guo Q; Harada R; Comley RA; Massarweh G; Soucy JP; Okamura N; Gauthier S; Rosa-Neto P
    Alzheimers Res Ther; 2017 Mar; 9(1):25. PubMed ID: 28359327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies.
    Ono M; Sahara N; Kumata K; Ji B; Ni R; Koga S; Dickson DW; Trojanowski JQ; Lee VM; Yoshida M; Hozumi I; Yoshiyama Y; van Swieten JC; Nordberg A; Suhara T; Zhang MR; Higuchi M
    Brain; 2017 Mar; 140(3):764-780. PubMed ID: 28087578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations of
    Harada R; Ishiki A; Kai H; Sato N; Furukawa K; Furumoto S; Tago T; Tomita N; Watanuki S; Hiraoka K; Ishikawa Y; Funaki Y; Nakamura T; Yoshikawa T; Iwata R; Tashiro M; Sasano H; Kitamoto T; Yanai K; Arai H; Kudo Y; Okamura N
    J Nucl Med; 2018 Apr; 59(4):671-674. PubMed ID: 28864633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau positron emission tomography using [
    Kang JM; Lee SY; Seo S; Jeong HJ; Woo SH; Lee H; Lee YB; Yeon BK; Shin DH; Park KH; Kang H; Okamura N; Furumoto S; Yanai K; Villemagne VL; Seong JK; Na DL; Ido T; Cho J; Lee KM; Noh Y
    Neurobiol Aging; 2017 Nov; 59():210-219. PubMed ID: 28890300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.
    Marquié M; Normandin MD; Vanderburg CR; Costantino IM; Bien EA; Rycyna LG; Klunk WE; Mathis CA; Ikonomovic MD; Debnath ML; Vasdev N; Dickerson BC; Gomperts SN; Growdon JH; Johnson KA; Frosch MP; Hyman BT; Gómez-Isla T
    Ann Neurol; 2015 Nov; 78(5):787-800. PubMed ID: 26344059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative evaluation of tau PET tracers
    Chen J; Li Y; Pirraglia E; Okamura N; Rusinek H; de Leon MJ;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1596-1604. PubMed ID: 29704038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET.
    Kikuchi A; Okamura N; Hasegawa T; Harada R; Watanuki S; Funaki Y; Hiraoka K; Baba T; Sugeno N; Oshima R; Yoshida S; Kobayashi J; Ezura M; Kobayashi M; Tano O; Mugikura S; Iwata R; Ishiki A; Furukawa K; Arai H; Furumoto S; Tashiro M; Yanai K; Kudo Y; Takeda A; Aoki M
    Neurology; 2016 Nov; 87(22):2309-2316. PubMed ID: 27794115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the radiolabeled metabolite of tau PET tracer
    Harada R; Furumoto S; Tago T; Furukawa K; Ishiki A; Tomita N; Iwata R; Tashiro M; Arai H; Yanai K; Kudo Y; Okamura N
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2211-2218. PubMed ID: 27430946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An autoradiographic evaluation of AV-1451 Tau PET in dementia.
    Lowe VJ; Curran G; Fang P; Liesinger AM; Josephs KA; Parisi JE; Kantarci K; Boeve BF; Pandey MK; Bruinsma T; Knopman DS; Jones DT; Petrucelli L; Cook CN; Graff-Radford NR; Dickson DW; Petersen RC; Jack CR; Murray ME
    Acta Neuropathol Commun; 2016 Jun; 4(1):58. PubMed ID: 27296779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report.
    Kim HJ; Cho H; Park S; Jang H; Ryu YH; Choi JY; Moon SH; Oh SJ; Oh M; Na DL; Lyoo CH; Kim EJ; Seeley WW; Kim JS; Choi KC; Seo SW
    BMC Neurol; 2019 Aug; 19(1):211. PubMed ID: 31464590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer's disease cases.
    Malarte ML; Nordberg A; Lemoine L
    Eur J Nucl Med Mol Imaging; 2021 Apr; 48(4):1093-1102. PubMed ID: 32970217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.